Common Indoor Mold and Pulmonary Disease Associated With Them

CHEST 2022 Coverage

S. Cherian

ATS 2022: Approach to Lung Nodules in 2022

Shaheen Islam

Post COVID-19 Lung Complications

3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

M. Padilla

Approaching Sarcoidosis Therapy From a 21st Century Perspective

CHEST 2022 Coverage

D. Culver

A Radiologist's Approach to Subsolid Pulmonary Nodules

CHEST 2022 Coverage

A. Guttentag

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Panel Discussion Chaired by Dr. Weichart on Big Data and How to Move…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Weichhart

Water-Borne Illness

OHSU

L. Strasfeld

An Update on Parapneumonic Effusions

McMaster University Department of Medicine

M. Chari

Advances and Updates in Sarcoidosis: Diagnosis and Treatment of Pulm…

UCLA Health

J. Belperio

Sarcoidosis: Diagnosis and Management

University of Colorado Department of Medicine

N. Held

Infectious Disease Update - What’s New in ID?

McMaster University Department of Medicine

A. Kapoor

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Short Course Antibiotic Therapy

McMaster University Department of Medicine

B. Spellberg

Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired…

MedCram

R. Seheult

ATS 2025 Insights: Applying the Guidelines: IPF, PPF, and CPFE

Insights from 2025 ATS Annual Meeting

C. Lee

Progressive Pulmonary Fibrosis (PPF): Part 2

Pulmonology Read Aloud

A. Aneja Arora

Rituximab versus Cyclophosphamide for the Treatment of Connective Ti…

Toby Maher